Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection.
Ooka Y, Miho K, Shuntaro O, Nakamura M, Ogasawara S, Suzuki E, Yasui S, Chiba T, Arai M, Kanda T, Maruyama H, Yokosuka O, Kato N, Mochizuki H, Omata M.
Ooka Y, et al. Among authors: arai m.
Hepatol Int. 2018 Nov;12(6):523-530. doi: 10.1007/s12072-018-9895-5. Epub 2018 Sep 21.
Hepatol Int. 2018.
PMID: 30242733